The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis

Fibrogenesis and Tissue Repair

Volumn 7, Issue 1, 2014, Pages

  Danobeitia, Juan S ^a   Djamali, Arjang ^a   Fernandez, Luis A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; ECULIZUMAB;

ALLOIMMUNITY; CELL DAMAGE; CHEMOTAXIS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DISEASE COURSE; HEMOLYTIC UREMIC SYNDROME; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; KIDNEY DONOR; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; STEM CELL; T LYMPHOCYTE; TISSUE REPAIR;

EID: 84920778336     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-7-16     Document Type: Review

References (104)

1. Ricklin D, Hajishengallis G, Yang K, Lambris JD: Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010, 11(9):785-797
2. Ricklin D, Lambris JD: Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol 2013, 190(8):3831-3838
3. Zipfel PF, Skerka C: Complement regulators and inhibitory proteins. Nat Rev Immunol 2009, 9(10):729-740
4. Blom AM, Villoutreix BO, Dahlbäck B: Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Mol Immunol 2004, 40(18):1333-1346
5. Józsi M, Zipfel PF: Factor H family proteins and human diseases. Trends Immunol 2008, 29(8):380-387
6. Davis AE: Biological effects of C1 inhibitor. Drug News Perspect 2004, 17(7):439-446
7. Eltzschig HK, Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med 2011, 17(11):1391-1401
8. Kono H, Rock KL: How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8(4):279-289
9. Friedewald JJ, Rabb H: Inflammatory cells in ischemic acute renal failure. Kidney Int 2004, 66(2):486-491
10. Bonventre JV, Zuk A: Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004, 66(2):480-485
11. Diepenhorst GM, van Gulik TM, Hack CE: Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg 2009, 249(6):889-899
12. Guo RF, Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol 2005, 23:821-852
13. McCaughan JA, O'Rourke DM, Courtney AE: The complement cascade in kidney disease: from sideline to center stage. Am J Kidney Dis 2013, 62(3):604-614
14. Gasque P: Complement: a unique innate immune sensor for danger signals. Mol Immunol 2004, 41(11):1089-1098
15. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH: Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000, 105(10):1363-1371
16. Weiser MR, Williams JP, Moore FD, Kobzik L, Ma M, Hechtman HB, Carroll MC: Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996, 183(5):2343-2348
17. Park P, Haas M, Cunningham PN, Bao L, Alexander JJ, Quigg RJ: Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Renal Physiol 2002, 282(2):F352-F357
18. Lin T, Zhou W, Farrar CA, Hargreaves RE, Sheerin NS, Sacks SH: Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. Am J Pathol 2006, 168(4):1241-1248
19. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM: Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 2003, 170(3):1517-1523
20. de Vries B, Walter SJ, Peutz-Kootstra CJ, Wolfs TG, van Heurn LW, Buurman WA: The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 2004, 165(5):1677-1688
21. Møller-Kristensen M, Wang W, Ruseva M, Thiel S, Nielsen S, Takahashi K, Shi L, Ezekowitz A, Jensenius JC, Gadjeva M: Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 2005, 61(5):426-434
22. Schwaeble WJ, Lynch NJ, Clark JE, Marber M, Samani NJ, Ali YM, Dudler T, Parent B, Lhotta K, Wallis R, Farrar CA, Sacks S, Lee H, Zhang M, Iwaki D, Takahashi M, Fujita T, Tedford CE, Stover CM: Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 2011, 108(18):7523-7528
23. van der Pol P, Schlagwein N, van Gijlswijk DJ, Berger SP, Roos A, Bajema IM, de Boer HC, de Fijter JW, Stahl GL, Daha MR, van Kooten C: Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation. Am J Transplant 2012, 12(4):877-887
24. Castellano G, Melchiorre R, Loverre A, Ditonno P, Montinaro V, Rossini M, Divella C, Battaglia M, Lucarelli G, Annunziata G, Palazzo S, Selvaggi FP, Staffieri F, Crovace A, Daha MR, Mannesse M, van Wetering S, Paolo Schena F, Grandaliano G: Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol 2010, 176(4):1648-1659
25. Berger SP, Roos A, Mallat MJ, Fujita T, de Fijter JW, Daha MR: Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005, 5(6):1361-1366
26. Damman J, Kok JL, Snieder H, Leuvenink HG, van Goor H, Hillebrands JL, van Dijk MC, Hepkema BG, Reznichenko A, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA: Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation. Mol Immunol 2012, 50(1-2):1-8
27. Bay JT, Sørensen SS, Hansen JM, Madsen HO, Garred P: Low mannose-binding lectin serum levels are associated with reduced kidney graft survival. Kidney Int 2013, 83(2):264-271
28. Heijnen BH, Straatsburg IH, Padilla ND, Van Mierlo GJ, Hack CE, Van Gulik TM: Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model. Clin Exp Immunol 2006, 143(1):15-23
29. Straatsburg IH, Boermeester MA, Wolbink GJ, van Gulik TM, Gouma DJ, Frederiks WM, Hack CE: Complement activation induced by ischemia-reperfusion in humans: a study in patients undergoing partial hepatectomy. J Hepatol 2000, 32(5):783-791
30. Williams JP, Pechet TT, Weiser MR, Reid R, Kobzik L, Moore FD, Carroll MC, Hechtman HB: Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) 1999, 86(3):938-942
31. Hill JH, Ward PA: The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 1971, 133(4):885-900
32. Jordan JE, Montalto MC, Stahl GL: Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 2001, 104(12):1413-1418
33. Sacks SH: Complement fragments C3a and C5a: the salt and pepper of the immune response. Eur J Immunol 2010, 40(3):668-670
34. Zhou W: The new face of anaphylatoxins in immune regulation. Immunobiology 2012, 217(2):225-234
35. van der Touw W, Cravedi P, Kwan WH, Paz-Artal E, Merad M, Heeger PS: Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J Immunol 2013, 190(12):5921-5925
36. Cravedi P, Leventhal J, Lakhani P, Ward SC, Donovan MJ, Heeger PS: Immune cell-derived C3a and C5a costimulate human T cell alloimmunity. Am J Transplant 2013, 13(10):2530-2539
37. Peng Q, Li K, Smyth LA, Xing G, Wang N, Meader L, Lu B, Sacks SH, Zhou W: C3a and C5a promote renal ischemia-reperfusion injury. J Am Soc Nephrol 2012, 23(9):1474-1485
38. de Vries B, Köhl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA: Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 2003, 170(7):3883-3889
39. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM: A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 2003, 63(1):134-142
40. Zheng X, Zhang X, Feng B, Sun H, Suzuki M, Ichim T, Kubo N, Wong A, Min LR, Budohn ME, Garcia B, Jevnikar AM, Min WP: Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol 2008, 173(4):973-980
41. Djamali A, Muth BL, Ellis TM, Mohamed M, Fernandez LA, Miller KM, Bellingham JM, Odorico JS, Mezrich JD, Pirsch JD, D'Alessandro TM, Vidyasagar V, Hofmann RM, Torrealba JR, Kaufman DB, Foley DP: Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients. Kidney Int 2013, 83(6):1185-1192
42. Stegall MD, Diwan T, Raghavaiah S, Cornell LD, Burns J, Dean PG, Cosio FG, Gandhi MJ, Kremers W, Gloor JM: Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 2011, 11(11):2405-2413
43. Lefaucheur C, Loupy A, Hill GS, Andrade J, Nochy D, Antoine C, Gautreau C, Charron D, Glotz D, Suberbielle-Boissel C: Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010, 21(8):1398-1406
44. Lerut E, Naesens M, Kuypers DR, Vanrenterghem Y, Van Damme B: Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year. Transplantation 2007, 83(11):1416-1422
45. Dean PG, Park WD, Cornell LD, Gloor JM, Stegall MD: Intragraft gene expression in positive crossmatch kidney allografts: ongoing inflammation mediates chronic antibody-mediated injury. Am J Transplant 2012, 12(6):1551-1563
46. Floerchinger B, Oberhuber R, Tullius SG: Effects of brain death on organ quality and transplant outcome. Transplant Rev (Orlando) 2012, 26(2):54-59
47. Danobeitia JS, Sperger JM, Hanson MS, Park EE, Chlebeck PJ, Roenneburg DA, Sears ML, Connor JX, Schwarznau A, Fernandez LA: Early activation of the inflammatory response in the liver of brain-dead non-human primates. J Surg Res 2012, 176(2):639-648
48. van der Hoeven J, Molema G, Ter Horst G, Freund R, Wiersema J, van Schilfgaarde R, Leuvenink H, Ploeg R: Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003, 64(5):1874-1882
49. Damman J, Schuurs TA, Ploeg RJ, Seelen MA: Complement and renal transplantation: from donor to recipient. Transplantation 2008, 85(7):923-927
50. Kusaka M, Pratschke J, Wilhelm MJ, Ziai F, Zandi-Nejad K, Mackenzie HS, Hancock WW, Tilney NL: Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000, 69(3):405-410
51. Pratt JR, Abe K, Miyazaki M, Zhou W, Sacks SH: In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol 2000, 157(3):825-831
52. Pratt JR, Basheer SA, Sacks SH: Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002, 8(6):582-587
53. Damman J, Nijboer WN, Schuurs TA, Leuvenink HG, Morariu AM, Tullius SG, van Goor H, Ploeg RJ, Seelen MA: Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant 2011, 26(7):2345-2354
54. Atkinson C, Varela JC, Tomlinson S: Complement-dependent inflammation and injury in a murine model of brain dead donor hearts. Circ Res 2009, 105(11):1094-1101
55. Damman J, Hoeger S, Boneschansker L, Theruvath A, Waldherr R, Leuvenink HG, Ploeg RJ, Yard BA, Seelen MA: Targeting complement activation in brain-dead donors improves renal function after transplantation. Transpl Immunol 2011, 24(4):233-237
56. Naesens M, Li L, Ying L, Sansanwal P, Sigdel TK, Hsieh SC, Kambham N, Lerut E, Salvatierra O, Butte AJ, Sarwal MM: Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol 2009, 20(8):1839-1851
57. Damman J, Seelen MA, Moers C, Daha MR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ: Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation 2011, 92(2):163-169
58. van Werkhoven MB, Damman J, van Dijk MC, Daha MR, de Jong IJ, Leliveld A, Krikke C, Leuvenink HG, van Goor H, van Son WJ, Olinga P, Hillebrands JL, Seelen MA: Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction. Am J Transplant 2013, 13(4):875-882
59. Blogowski W, Dolegowska B, Salata D, Budkowska M, Domanski L, Starzynska T: Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation. Clin J Am Soc Nephrol 2012, 7(11):1843-1851
60. de Vries DK, van der Pol P, van Anken GE, van Gijlswijk DJ, Damman J, Lindeman JH, Reinders ME, Schaapherder AF, Kooten C: Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation. Transplantation 2013, 95(6):816-820
61. Mastellos DC, Deangelis RA, Lambris JD: Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis. Semin Immunol 2013, 25(1):29-38
62. Vasel M, Rutz R, Bersch C, Feick P, Singer MV, Kirschfink M, Nakchbandi IA: Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C. Clin Immunol 2014, 150(2):149-156
63. Khan MA, Nicolls MR: Complement-mediated microvascular injury leads to chronic rejection. Adv Exp Med Biol 2013, 735:233-246
64. Khan MA, Maasch C, Vater A, Klussmann S, Morser J, Leung LL, Atkinson C, Tomlinson S, Heeger PS, Nicolls MR: Targeting complement component 5a promotes vascular integrity and limits airway remodeling. Proc Natl Acad Sci U S A 2013, 110(15):6061-6066
65. DeAngelis RA, Markiewski MM, Kourtzelis I, Rafail S, Syriga M, Sandor A, Maurya MR, Gupta S, Subramaniam S, Lambris JD: A complement-IL-4 regulatory circuit controls liver regeneration. J Immunol 2012, 188(2):641-648
66. Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE, Lambris JD: The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003, 198(6):913-923
67. He S, Atkinson C, Qiao F, Cianflone K, Chen X, Tomlinson S: A complementdependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. J Clin Invest 2009, 119(8):2304-2316
68. Su Z, Wang X, Gao X, Liu Y, Pan C, Hu H, Beyer RP, Shi M, Zhou J, Zhang J, Serra AL, Wüthrich RP, Mei C: Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Intern Med 2014, In press
69. Hepburn NJ, Ruseva MM, Harris CL, Morgan BP: Complement, roles in renal disease and modulation for therapy. Clin Nephrol 2008, 70(5):357-376
70. Mele C, Remuzzi G, Noris M: Hemolytic uremic syndrome. Semin Immunopathol 2014, In press
71. Sacks SH, Zhou W: The role of complement in the early immune response to transplantation. Nat Rev Immunol 2012, 12(6):431-442
72. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011, 121(11):4210-4221
73. Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK: Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2008, 23(3):842-852
74. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA: Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 2003, 285(2):F191-F198
75. Basile DP: The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007, 72(2):151-156
76. Koo DD, Welsh KI, West NE, Channon KM, Penington AJ, Roake JA, Morris PJ, Fuggle SV: Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase. Kidney Int 2001, 60(2):786-796
77. Tipping PG, Huang XR, Berndt MC, Holdsworth SR: A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int 1994, 46(1):79-88
78. Boor P, Konieczny A, Villa L, Schult AL, Bücher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T: Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol 2007, 18(5):1508-1515
79. Bao L, Wang Y, Haas M, Quigg RJ: Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury. Kidney Int 2011, 80(5):524-534
80. Guerrot D, Dussaule J-C, Kavvadas P, Boffa J-J, Chadjichristos CE, Chatziantoniou C: Progression of renal fibrosis: the underestimated role of endothelial alterations. Fibrogenesis Tissue Repair 2012, 5(Suppl 1):S15
81. Basile DP, Friedrich JL, Spahic J, Knipe N, Mang H, Leonard EC, Changizi-Ashtiyani S, Bacallao RL, Molitoris BA, Sutton TA: Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 2011, 300(3):F721-F733
82. Curci C, Castellano G, Stasi A, Divella C, Loverre A, Gigante M, Simone S, Cariello M, Montinaro V, Lucarelli G, Ditonno P, Battaglia M, Crovace A, Staffieri F, Oortwijn B, van Amersfoort E, Gesualdo L, Grandaliano G: Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant 2014, 29(4):799-808
83. Wan JX, Fukuda N, Endo M, Tahira Y, Yao EH, Matsuda H, Ueno T, Matsumoto K: Complement 3 is involved in changing the phenotype of human glomerular mesangial cells. J Cell Physiol 2007, 213(2):495-501
84. Rangan GK, Pippin JW, Couser WG: C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int 2004, 66(5):1838-1848
85. Ricardo SD, van Goor H, Eddy AA: Macrophage diversity in renal injury and repair. J Clin Invest 2008, 118(11):3522-3530
86. Mannon RB: Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? Curr Opin Organ Transplant 2012, 17(1):20-25
87. Li L, Huang L, Sung SS, Vergis AL, Rosin DL, Rose CE Jr, Lobo PI, Okusa MD: The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Inter 2008, 74(12):1526-1537
88. Phieler J, Chung K-J, Chatzigeorgiou A, Ameln AK-v, Garcia-Martin R, Sprott D, Moisidou M, Tzanavari T, Ludwig B, Baraban E, Ehrhart-Bornstein M, Bornstein SR, Mziaut H, Solimena M, Karalis KP, Economopoulou M, Lambris JD, Chavakis T: The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance. J Immunol 2013, 191(8):4367-4374
89. Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87(1):245-313
90. Gill PS, Wilcox CS: NADPH oxidases in the kidney. Antioxid Redox Signal 2006, 8(9-10):1597-1607
91. Gardinali M, Padalino P, Vesconi S, Calcagno A, Ciappellano S, Conciato L, Chiara O, Agostoni A, Nespoli A: Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. Arch Surg 1992, 127(10):1219-1224
92. Igonin AA, Protsenko DN, Galstyan GM, Vlasenko AV, Khachatryan NN, Nekhaev IV, Shlyapnikov SA, Lazareva NB, Herscu P: C1-esterase inhibitor infusion increases survival rates for patients with sepsis*. Crit Care Med 2012, 40(3):770-777
93. Djamali A, Reese S, Hafez O, Vidyasagar A, Jacobson L, Swain W, Kolehmainen C, Huang L, Wilson NA, Torrealba JR: Nox2 is a mediator of chronic CsA nephrotoxicity. Am J Transplant 2012, 12(8):1997-2007
94. Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S: Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant 2009, 9(1):74-82
95. Davis AE, Lu F, Mejia P: C1 inhibitor, a multi-functional serine protease inhibitor. Thromb Haemost 2010, 104(5):886-893
96. Frank MM: Recombinant and plasma-purified human c1 inhibitor for the treatment of hereditary angioedema. World Allergy Organ J 2010, 3(9 Suppl):S29-S33
97. Lu F, Chauhan AK, Fernandes SM, Walsh MT, Wagner DD, Davis AE: The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2008, 295(5):G1042-G1049
98. Lu F, Fernandes SM, Davis AE: The effect of C1 inhibitor on myocardial ischemia and reperfusion injury. Cardiovasc Pathol 2013, 22(1):75-80
99. Saidi RF, Rajeshkumar B, Shariftabrizi A, Dresser K, Walter O: Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration. J Surg Res 2014, 187(2):660-666
100. Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M, De Simoni MG: Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol 2009, 66(3):332-342
101. Tillou X, Poirier N, Le Bas-Bernardet S, Hervouet J, Minault D, Renaudin K, Vistoli F, Karam G, Daha M, Soulillou JP, Blancho G: Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons. Kidney Int 2010, 78(2):152-159
102. Sommer W, Tudorache I, Kühn C, Avsar M, Salman J, Ius F, Gras C, Weber P, Welte T, Gottlieb J, Haverich A, Warnecke G: C1-esterase-inhibitor for primary graft dysfunction in lung transplantation. Transplantation 2014, 97(11):1185-1191
103. Barnett AN, Asgari E, Chowdhury P, Sacks SH, Dorling A, Mamode N: The use of eculizumab in renal transplantation. Clin Transplant 2013, 27(3):E216-E229
104. De Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA: Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 2003, 75(3):375-382